Retrospective cohort links psychedelic intensity during sublingual ketamine treatment to antidepressant outcomes
Psychedelic experience intensity during ketamine treatment and antidepressant outcomes.
A retrospective longitudinal cohort study of 3,637 adults with moderate-to-severe depression reports that higher subjective psychedelic intensity at 2 weeks of sublingual ketamine treatment was associated with greater reductions in depression severity at 4 weeks.
Key facts
- Kind of item
- Papers
- Compound
- Ketamine and esketamine
- Condition
- Depression
- Jurisdiction
- United States
- Participants
- 3,637 adults (as written in the text)
- Source
- Europe PMC: new psychedelic research papers (europepmc.org)
- Published
- Original
- Read it at europepmc.org
How this summary was made
The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Europe PMC: new psychedelic research papers · europepmc.org
Connected to
- Kind of item
- Papers
- Compound
- Ketamine and esketamine
- Condition
- Depression
- Jurisdiction
- United States
- Theme
- Mechanisms